130 related articles for article (PubMed ID: 4718925)
21. Immune complexes and visceral deposits of measles antigens in subacute sclerosing panencephalitis.
Dayan AD; Stokes MI
Br Med J; 1972 May; 2(5810):374-6. PubMed ID: 4554157
[TBL] [Abstract][Full Text] [Related]
22. [Subacute sclerosing panencephalitis and measles encephalitis: results of comparative studies between the SSPE virus and other measles virus strains].
Käckell MY; ter Meulen V; Meyermann R; Müller D; Joppich GJ
Monatsschr Kinderheilkd (1902); 1974 Jul; 122(7):426-8. PubMed ID: 4605971
[No Abstract] [Full Text] [Related]
23. Oligoclonal measles virus-specific IgG antibodies isolated from sera of patients with subacute sclerosing panencephalitis.
Vandvik B
Scand J Immunol; 1977; 6(6-7):641-9. PubMed ID: 905775
[TBL] [Abstract][Full Text] [Related]
24. Immunological response of subacute sclerosing panencephalitis patients to measles virus.
Madden DL; Fuccillo DA; Castellano G; Traub R; Krezlewicz A; Sever JL
Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):509-20. PubMed ID: 616551
[TBL] [Abstract][Full Text] [Related]
25. Subacute sclerosing panencephalitis after passive immunization and natural measles infection: role of antibody in persistence of measles virus.
Rammohan KW; McFarland HF; McFarlin DE
Neurology; 1982 Apr; 32(4):390-4. PubMed ID: 7199661
[TBL] [Abstract][Full Text] [Related]
26. [Studies on the interaction between cells infected with measles virus and anti-measles antibody. I. Cytotoxic antibody activity of sera obtained from patients with natural measles and subacute sclerosing panencephalitis by use of chronically infected cell lines].
Kuwajima S
Hokkaido Igaku Zasshi; 1986 Jan; 61(1):5-14. PubMed ID: 3699682
[TBL] [Abstract][Full Text] [Related]
27. Subacute sclerosing panencephalitis.
Connolly JH
J Clin Pathol Suppl (R Coll Pathol); 1972; 6():73-7. PubMed ID: 4616969
[No Abstract] [Full Text] [Related]
28. Subacute sclerosing panencephalitis: measles encephalitis of temperate evolution?
Dayan AD
Postgrad Med J; 1969 Jun; 45(524):401-7. PubMed ID: 5798690
[TBL] [Abstract][Full Text] [Related]
29. Low molecular weight measles immunoglobulin M in subacute sclerosing panencephalitis and acute measles.
Connolly JH; Simpson DM; Trudgett A; Hopkins AP
Postgrad Med J; 1985 May; 61(715):407-10. PubMed ID: 4022875
[TBL] [Abstract][Full Text] [Related]
30. Measles, measles vaccination, and risk of subacute sclerosing panencephalitis (SSPE).
Zilber N; Rannon L; Alter M; Kahana E
Neurology; 1983 Dec; 33(12):1558-64. PubMed ID: 6685828
[TBL] [Abstract][Full Text] [Related]
31. Specific inhibitory factors of cellular immunity in children with subacute sclerosing panencephalitis.
Steele RW; Fuccillo DA; Hensen SA; Vincent MM; Bellanti JA
J Pediatr; 1976 Jan; 88(1):56-62. PubMed ID: 812971
[TBL] [Abstract][Full Text] [Related]
32. Cellular and humoral responses to measles in subacute sclerosing panencephalitis.
Saunders M; Chambers ME; Knowles M; Caspary EA; Gardner-Medwin D; Walker P
Lancet; 1969 Jan; 1(7585):72-4. PubMed ID: 4178001
[No Abstract] [Full Text] [Related]
33. Frequency, serodiagnosis and epidemiological features of subacute sclerosing panencephalitis (SSPE) and epidemiology and vaccination policy for measles in the Federal Republic of Germany (FRG).
Enders-Ruckle G
Dev Biol Stand; 1978; 41():195-207. PubMed ID: 381072
[TBL] [Abstract][Full Text] [Related]
34. Presence of oligoclonal immunoglobulin G bands and lack of matrix protein antibodies in cerebrospinal fluids and sera of ferrets with measles virus encephalitis.
Thormar H; Mehta PD; Lin FH; Brown HR; Wisniewski HM
Infect Immun; 1983 Sep; 41(3):1205-11. PubMed ID: 6885159
[TBL] [Abstract][Full Text] [Related]
35. Transfer factor therapy in patients with subacute sclerosing panencephalitis.
Käckell YM; Grob PJ; Kreth WH; Kibler R; Meulen V
J Neurol; 1975 Dec; 211(1):39-49. PubMed ID: 56430
[TBL] [Abstract][Full Text] [Related]
36. Demonstration of a blocking factor in the plasma and spinal fluid of patients with subacute sclerosing panencephalitis. I. Partial characterization.
Ahmed A; Strong DM; Sell KW; Thurman GB; Knudsen RC; Wistar R; Grace WR
J Exp Med; 1974 Apr; 139(4):902-24. PubMed ID: 4593239
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of antibodies against measles virus and myelin by in vitro stimulated B-cells derived from patients with subacute sclerosing panencephalitis.
Wirguin I; Steinitz M; Sicsic C; Abramsky O; Brenner T
Immunol Lett; 1993 Sep; 38(1):55-8. PubMed ID: 7507883
[TBL] [Abstract][Full Text] [Related]
38. Virological and immunological studies in experimental SSPE.
Johnson KP; Byington DP; Gaddis L
Neurol Neurocir Psiquiatr; 1977; 18(2-3 Suppl):495-507. PubMed ID: 616550
[TBL] [Abstract][Full Text] [Related]
39. Increased insulin-like growth factor-1 levels in cerebrospinal fluid of advanced subacute sclerosing panencephalitis patients.
Yılmaz D; Yüksel D; Gökkurt D; Oguz H; Anlar B
Eur J Paediatr Neurol; 2016 Jul; 20(4):611-5. PubMed ID: 27061773
[TBL] [Abstract][Full Text] [Related]
40. Imbalance of k/lambda ratios associated with high measles antibody titers in fractionated serum immunoglobulins of patients affected with subacute sclerosing panencephalitis.
Bollengier F; Karcher D; Rabinovitch N
Ann Microbiol (Paris); 1977 Jan; 128A(1):89-96. PubMed ID: 405900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
